The evolving role of letrozole in the adjuvant setting: First results from the large, phase III, randomized trial BIG 1-98-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The evolving role of letrozole in the adjuvant setting: First results from the large, phase III, randomized trial BIG 1-98

Published:2006-02 Issue:1 Volume:15 Page:21-29
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Monnier A.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference29 articles.

1. Tamoxifen for early breast cancer: an overview of the randomised trials;Lancet,1998

2. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J Natl Cancer Inst,1998

3. Overview of the main outcomes in breast-cancer prevention trials;Cuzick;Lancet,2003

4. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial;Fisher;J Natl Cancer Inst,2001

5. Are all aromatase inhibitors the same? A review of the current evidence;Janicke;Breast,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A convenient synthesis of NiO-CuS/molecularly imprinted polymer nanocomposites with highly enhanced adsorption activity and selectivity for removal of Letrozole;Polymer-Plastics Technology and Materials;2019-09-26

2. Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis;Therapeutic Advances in Musculoskeletal Disease;2018-03-22

3. Aromatase inhibitors;Meyler's Side Effects of Drugs;2016

4. Synthesis and characterization of poly[1-(N,N-bis-carboxymethyl)amino-3-allylglycerol-co-dimethylacrylamide] grafted to magnetic nano-particles for extraction and determination of letrozole in biological and pharmaceutical samples;Talanta;2013-12

5. Approval Summary: Letrozole (Femara® Tablets) for Adjuvant and Extended Adjuvant Postmenopausal Breast Cancer Treatment: Conversion of Accelerated to Full Approval;The Oncologist;2011-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3